XML 67 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2013
Notes to Condensed Consolidated Financial Statements [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]
 
June 30, 2013
 
December 31, 2012
(Dollars in millions)
Derivatives
designated
as hedging
instruments
 
Derivatives not
designated as
hedging
instruments
 
Derivatives
designated
as hedging
instruments
 
Derivatives not
designated as
hedging
instruments
Balance Sheet Asset Locations:
 
 
 
 
 
 
 
Other assets, current
$
8

 
$
82

 
$
48

 
$
47

Other assets
3

 
5

 
30

 
3

 
11

 
87

 
78

 
50

Total Asset Derivative Contracts
 
 
$
98

 
 
 
$
128

Balance Sheet Liability Locations:
 
 
 
 
 
 
 
Accrued liabilities
$
53

 
$
111

 
$
10

 
$
136

Other long-term liabilities
40

 
1

 
1

 
2

 
93

 
112

 
11

 
138

Total Liability Derivative Contracts
 
 
$
205

 
 
 
$
149

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
 
Quarter Ended June 30,
 
Six Months Ended June 30,
(Dollars in millions)
2013
 
2012
 
2013
 
2012
Loss recorded in Accumulated other comprehensive loss
$
(64
)
 
$
(155
)
 
$
(161
)
 
$
(63
)
Loss reclassified from Accumulated other comprehensive loss into Product sales (effective portion)
$
(15
)
 
$
(8
)
 
$
(23
)
 
$
(19
)
Schedule of Foreign Exchange Contracts Not Designated as Hedges, Gain (Loss) In Statement of Financial Performance [TextBlock]
 
Quarter Ended June 30,
 
Six Months Ended June 30,
(Dollars in millions)
2013
 
2012
 
2013
 
2012
(Loss) gain recognized in Other income, net
$
(9
)
 
$
(78
)
 
$
23

 
$
(40
)
Fair Value, Measurement Inputs, Disclosure [Text Block]
(Dollars in millions)
Total Carrying
Value at
December 31,
2012
 
Quoted price in
active markets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Unobservable
inputs
(Level 3)
Recurring fair value measurements:
 
 
 
 
 
 
 
Available-for-sale securities
$
781

 
$
781

 
$

 
$

Derivative assets
128

 

 
128

 

Derivative liabilities
(149
)
 

 
(149
)
 

Nonrecurring fair value measurements:
 
 
 
 
 
 
 
Equity method investment
432

 

 
432

 

Business dispositions
84

 

 
84

 

(Dollars in millions)
Total Carrying
Value at
June 30, 2013
 
Quoted price in
active markets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Unobservable
inputs
(Level 3)
Recurring fair value measurements:
 
 
 
 
 
 
 
Available-for-sale securities
$
827

 
$
827

 
$

 
$

Derivative assets
98

 

 
98

 

Derivative liabilities
(205
)
 

 
(205
)
 

Nonrecurring fair value measurements:
 
 
 
 
 
 
 
Business dispositions
13

 

 
13

 

Fair Value, by Balance Sheet Grouping [Text Block]
 
June 30, 2013
 
December 31, 2012
(Dollars in millions)
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
Long-term receivables
$
646

 
$
586

 
$
499

 
$
464

Customer financing notes receivable
408

 
354

 
375

 
371

Short-term borrowings
(196
)
 
(196
)
 
(503
)
 
(503
)
Long-term debt (excluding capitalized leases)
(21,412
)
 
(21,890
)
 
(22,665
)
 
(25,606
)
Long-term liabilities
(279
)
 
(250
)
 
(182
)
 
(167
)
(Dollars in millions)
Total Fair
Value at
June 30,
2013
 
Quoted price in
active markets
(Level 1)
 
Significant other
observable inputs
(Level 2)
 
Unobservable
inputs
(Level 3)
Long-term receivables
$
586

 
$

 
$
586

 
$

Customer financing notes receivable
354

 

 
354

 

Short-term borrowings
(196
)
 

 
(50
)
 
(146
)
Long-term debt (excluding capitalized leases)
(21,890
)
 

 
(21,787
)
 
(103
)
Long-term liabilities
(250
)
 

 
(250
)